Authors:
Neville, C
Whalley, D
McKenna, S
Le Comte, M
Fortin, PR
Citation: C. Neville et al., Adaptation and validation of the rheumatoid arthritis quality of life scale for use in Canada, J RHEUMATOL, 28(7), 2001, pp. 1505-1510
Authors:
Neville, C
Clarke, AE
Joseph, L
Belisle, P
Ferland, D
Fortin, PR
Citation: C. Neville et al., Learning from discordance in patient and physician global assessments of systemic lupus erythematosus disease activity, J RHEUMATOL, 27(3), 2000, pp. 675-679
Authors:
Lucey, MD
Newkirk, MM
Neville, C
Lepage, K
Fortin, PR
Citation: Md. Lucey et al., Association between IgM response to IgG damaged by glyoxidation and disease activity in rheumatoid arthritis, J RHEUMATOL, 27(2), 2000, pp. 319-323
Citation: Jc. Yen et al., Discordance between patients and their physicians in the assessment of lupus disease activity: relevance for clinical trials, LUPUS, 8(8), 1999, pp. 660-670
Authors:
Moore, AD
Clarke, AE
Danoff, DS
Joseph, L
Belisle, P
Neville, C
Fortin, PR
Citation: Ad. Moore et al., Can health utility measures be used in lupus research? A comparative validation and reliability study of 4 utility indices, J RHEUMATOL, 26(6), 1999, pp. 1285-1290
Authors:
Newkirk, MM
Apostolakos, P
Neville, C
Fortin, PR
Citation: Mm. Newkirk et al., Systemic lupus erythematosus, a disease associated with low levels of clusterin/ApoJ, an antiinflammatory protein, J RHEUMATOL, 26(3), 1999, pp. 597-603
Authors:
Hebert, RL
O'Connor, T
Neville, C
Burns, KD
Laneuville, O
Peterson, LN
Citation: Rl. Hebert et al., Prostanoid signaling, localization, and expression of IP receptors in rat thick ascending limb cells, AM J P-REN, 44(6), 1998, pp. F904-F914
Authors:
Rauch, J
Tannenbaum, M
Neville, C
Fortin, PR
Citation: J. Rauch et al., Inhibition of lupus anticoagulant activity by hexagonal phase phosphatidylethanolamine in the presence of prothrombin, THROMB HAEM, 80(6), 1998, pp. 936-941